Clinical Evidence: What Wegovy Weight Loss Trials Actually Show
Understanding Why Weight Loss Results Vary on Wegovy
When patients ask "why am I not losing weight on Wegovy", the answer often lies in understanding individual response variation within clinical trial parameters. In the STEP 1 trial (Wilding et al., NEJM, 2021), whilst the average weight loss was ~15% at 68 weeks, results ranged significantly between participants. Some achieved greater than clinically studied weight loss, whilst others experienced more modest results around 5-10%.
The key factors influencing Wegovy weight loss results include adherence to the prescribed reduced-calorie diet and increased physical activity, individual metabolic differences, starting BMI, and concurrent medications. UK patients often wonder why their weight loss trajectory doesn't match clinical trial averages, but this variation is entirely normal and documented within the research data.
Wegovy Pricing and Value for UK Weight Loss Results
EverydayMeds offers transparent Wegovy pricing to support your weight management journey, starting with the 0.25mg starter dose at £79.99. Our Getting Started bundles provide excellent value, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, covering your first 8 weeks of treatment. New customers benefit from our FIRST40 discount code applied at checkout, whilst returning customers use DOSE25.
For patients questioning "why am I not losing weight on Wegovy" and considering long-term commitment, our maintenance options include the 2.4mg dose at £209.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99. This prescription-only medicine requires ongoing investment, but our bundle options provide convenient supply continuity without multiple orders.
STEP Trial Evidence: What Clinical Research Shows About Wegovy Weight Loss
The STEP clinical programme provides robust evidence for patients questioning Wegovy's effectiveness. STEP 1 demonstrated ~15% average weight loss versus ~2.4% with placebo, whilst STEP 3 showed ~16% when combined with intensive behavioural therapy. Importantly, STEP 5 confirmed sustained weight loss of ~15.2% at 2 years, addressing long-term effectiveness concerns.
For UK patients asking "why am I not losing weight on Wegovy", it's crucial to understand that these trials required participants to follow a reduced-calorie diet and increased physical activity programme. The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events, showing benefits beyond weight loss alone.
How Wegovy Works: The GLP-1 Mechanism Behind Weight Loss
Understanding Wegovy's mechanism helps explain why weight loss results vary and why some patients initially wonder "why am I not losing weight on Wegovy". Semaglutide is a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. This prescription-only medicine works by reducing appetite and promoting feelings of fullness after smaller meals, whilst potentially reducing food cravings by acting on brain appetite centres. The weekly FlexTouch injection provides consistent medication levels, but individual receptor sensitivity varies between patients. The dose escalation protocol (0.25mg to 2.4mg over 16 weeks) allows your body to adjust gradually whilst minimising side effects that might impact treatment adherence.
EverydayMeds Ordering Process: Getting Started with Wegovy
Accessing Wegovy through EverydayMeds involves a streamlined 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our UK-registered prescribers review applications within 3 working days (express 24-hour service available), ensuring appropriate prescribing for this prescription-only medicine. Once approved, your genuine Novo Nordisk Wegovy pens are dispatched via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance and authentic product supply. For patients asking "why am I not losing weight on Wegovy", our clinical team provides ongoing support and guidance on optimising results within the licensed indication parameters.
Storage and Practical Wegovy Management
Proper Wegovy storage significantly impacts treatment effectiveness, which may explain some cases where patients wonder "why am I not losing weight on Wegovy". Store unopened pens in your fridge at 2-8°C, though Wegovy offers excellent travel flexibility with 6 weeks room temperature tolerance below 30°C once removed from refrigeration. The FlexTouch pen design ensures accurate dosing, and the mandatory dose escalation schedule (starting at 0.25mg weekly) helps minimise gastrointestinal side effects that could impact adherence. Each pen contains 4 doses, and maintaining consistent weekly injection timing optimises the medication's appetite-suppressing effects. Never skip or accelerate doses, as this can affect both tolerability and weight loss outcomes, potentially contributing to suboptimal results.
Realistic Weight Loss Timeline Expectations with Wegovy
Many patients asking "why am I not losing weight on Wegovy" may have unrealistic timeline expectations based on anecdotal reports rather than clinical evidence. The STEP trials show that significant weight loss typically becomes apparent after reaching higher doses (1mg-2.4mg), which occurs between weeks 9-17 of treatment. Initial weeks focus on dose escalation and side effect management rather than dramatic weight changes.
UK clinical practice shows that patients often experience their most significant weight loss between months 3-9 of treatment, with continued gradual loss thereafter. The STEP 5 data demonstrates that sustained results require ongoing treatment, as weight regain occurred when participants discontinued Wegovy. Setting realistic expectations based on clinical evidence rather than social media success stories helps maintain treatment motivation and adherence.
Order Wegovy Today: Start Your Evidence-Based Weight Loss Journey
If you're still wondering "why am I not losing weight on Wegovy" or considering starting treatment, EverydayMeds provides transparent access to this prescription-only medicine with full clinical support. Use discount code FIRST40 for new customers or DOSE25 for returning customers, applied at checkout to access our competitive pricing from £79.99. Our UK prescribers evaluate your suitability within the licensed indication parameters, ensuring appropriate treatment for adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. Order through our secure platform at https://everydaymeds.co.uk/collections/wegovy and begin your clinically-supported weight management programme. Remember that Wegovy works best alongside a reduced-calorie diet and increased physical activity, and individual results will vary as demonstrated in the published clinical trials.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
